Future studies will determine whether any of these molecules contribute to the suppression of RhoA by BCAR3 and, in so doing, help to elucidate the mechanism by which BCAR3 affects the balance between Rac1 and RhoA signaling in invasive breast cancer cells. The gene discussed is RAC1; the disease is breast cancer.